![](https://investorshub.advfn.com/uicon/104073.png?cb=1465932499)
Friday, June 17, 2022 10:09:57 AM
Recent ADXN News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/15/2024 10:05:04 AM
- Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS) • GlobeNewswire Inc. • 07/15/2024 05:00:00 AM
- Addex To Present at the Thirteenth London International Cough Symposium (13th LICS) • GlobeNewswire Inc. • 07/12/2024 05:00:00 AM
- Addex Shareholders Approve All Resolutions at Annual General Meeting • GlobeNewswire Inc. • 07/01/2024 05:00:00 AM
- US Index Futures Mixed; Oil Prices Rise • IH Market News • 06/06/2024 11:29:43 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/06/2024 10:00:32 AM
- Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 06/06/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/05/2024 10:05:04 AM
- Addex Convenes Annual General Meeting 2024 • GlobeNewswire Inc. • 06/05/2024 05:00:00 AM
- Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024 • GlobeNewswire Inc. • 05/31/2024 05:00:00 AM
- Addex to Present at Bio€quity Europe 2024 • GlobeNewswire Inc. • 05/08/2024 05:00:00 AM
- Addex Provides Update on ADX71149 Phase 2 Epilepsy Study • GlobeNewswire Inc. • 04/29/2024 05:00:00 AM
- Addex to Present at the Swiss Biotech Day 2024 • GlobeNewswire Inc. • 04/19/2024 05:00:00 AM
- Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 04/18/2024 05:00:00 AM
- Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024 • GlobeNewswire Inc. • 04/11/2024 05:00:00 AM
- Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders • GlobeNewswire Inc. • 04/03/2024 05:00:00 AM
- Addex to Present at the Bio-Europe Spring 2024 Conference • GlobeNewswire Inc. • 03/14/2024 06:00:00 AM
- Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC. • GlobeNewswire Inc. • 01/31/2024 06:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/30/2024 10:00:28 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/30/2024 09:58:12 PM
- Addex to Present at the Swiss Equities Baader Conference • GlobeNewswire Inc. • 01/09/2024 06:00:00 AM
- Addex to Present at Biotech Showcase™ 2024 • GlobeNewswire Inc. • 01/05/2024 06:30:00 AM
- Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend] • Edgar (US Regulatory) • 12/21/2023 11:00:58 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/20/2023 11:05:05 AM
- Addex Shareholders Approve All Resolutions at Extraordinary General Meeting • GlobeNewswire Inc. • 12/20/2023 06:00:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM